| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | KX2-391 | CTRPv2 | pan-cancer | AAC | 0.15 | 3e-06 |
| mRNA | ceranib-2 | CTRPv2 | pan-cancer | AAC | 0.15 | 5e-06 |
| mRNA | dinaciclib | CTRPv2 | pan-cancer | AAC | 0.2 | 6e-05 |
| mRNA | parbendazole | CTRPv2 | pan-cancer | AAC | 0.12 | 8e-05 |
| mRNA | vincristine | CTRPv2 | pan-cancer | AAC | 0.12 | 8e-05 |
| mRNA | ML311 | CTRPv2 | pan-cancer | AAC | 0.13 | 8e-05 |
| mRNA | GSK461364 | CTRPv2 | pan-cancer | AAC | 0.12 | 9e-05 |
| mRNA | necrosulfonamide | CTRPv2 | pan-cancer | AAC | 0.15 | 0.0001 |
| mRNA | SCH-79797 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0001 |
| mRNA | THZ-2-102-1 | GDSC1000 | pan-cancer | AAC | 0.11 | 0.0001 |